论文部分内容阅读
目的:探讨微清蛋白尿的检测在肝癌患者术后液体治疗中的应用价值。方法:选择接受手术治疗的肝癌患者作为对象,出现微清蛋白尿者观察组(26例),未出现微清蛋白尿者对照组(34例),检测肾功能指标、免疫功能指标,观察脏器积液情况。结果:观察组患者血肌酐、血尿素氮、24小时尿蛋白、CD8+含量、脏器积液的例数和引流量均明显高于对照组,内生肌酐清除率和CD3+,CD4+,CD4+/CD8+,NK含量明显低于对照组。结论:微量清蛋白尿对于判断肝癌术后液体治疗的机体状态具有积极意义。
Objective: To investigate the value of detection of microalbuminuria in the treatment of postoperative patients with liver cancer. Methods: Patients with hepatocellular carcinoma (HCC) undergoing surgical treatment were selected as the observation group. The patients with microalbuminuria (26 cases) and the patients without microalbuminuria (34 cases) were enrolled in this study. Renal function, immune function, Fluid condition. Results: Serum creatinine, blood urea nitrogen, 24-hour urinary protein, CD8 + and organ effusion in the observation group were significantly higher than those in the control group. The clearance rate of endogenous creatinine and CD3 +, CD4 +, CD4 + / CD8 + , NK content was significantly lower than the control group. Conclusion: Microalbuminuria is of positive significance for judging the status of postoperative fluid therapy of liver cancer.